These results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two aid the strategy of concentrating on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Conditions. January 3, 2024 Donating is https://atecac384arh9.thekatyblog.com/profile